WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H524717
CAS#: 89239-35-0
Description: CI 943 is a novel potential antipsychotic agent. It does not bind to dopamine (DA) receptors, making it an agent of great interest.
Hodoodo Cat#: H524717
Name: CI 943
CAS#: 89239-35-0
Chemical Formula: C12H17N5
Exact Mass: 231.15
Molecular Weight: 231.300
Elemental Analysis: C, 62.31; H, 7.41; N, 30.28
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: CI 943; CI-943; CI943.
IUPAC/Chemical Name: 7,8-Dihydro-8-ethyl-1,3,5-trimethyl-1H-imidazo(1,2-c)pyrazolo(3,4-e)pyrimidine
InChi Key: YFAVYALYCRERKH-SECBINFHSA-N
InChi Code: InChI=1S/C12H17N5/c1-5-9-6-17-8(3)13-10-7(2)15-16(4)11(10)12(17)14-9/h9H,5-6H2,1-4H3/t9-/m1/s1
SMILES Code: C=1(N2C(c3c(N1)c(nn3C)C)=N[C@@H](C2)CC)C
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 231.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Liégeois JF, Bonaventure P, Delarge J, Damas J. Antipsychotics and neuropeptides: the atypical profile of CI-943 and its relationship to neurotensin. Neurosci Biobehav Rev. 1995 Winter;19(4):519-31. Review. Erratum in: Neurosci Biobehav Rev 1996 Summer;20(2):I. PubMed PMID: 8684714.
2: Henck JW, Petrere JA, Anderson JA. Developmental neurotoxicity of CI-943: a novel antipsychotic. Neurotoxicol Teratol. 1995 Jan-Feb;17(1):13-24. PubMed PMID: 7708015.
3: Levant B, Bissette G, Davis MD, Heffner TG, Nemeroff CB. Effects of CI-943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations. Synapse. 1991 Nov;9(3):225-30. PubMed PMID: 1685600.
4: Krcmarik CS, Miceli JJ, Pachla LA. High-performance liquid chromatographic assay for a novel psychotropic drug (CI-943) in cynomolgus monkey plasma. J Chromatogr. 1989 Nov 24;496(2):493-9. PubMed PMID: 2613852.
5: Meltzer LT, Christoffersen CL, Heffner TG, Freeman AS, Chiodo LA. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity. J Pharmacol Exp Ther. 1989 Oct;251(1):123-30. PubMed PMID: 2571714.
6: Pugsley TA, Coughenour LL, Myers SL, Shih YH, Courtland GG, Berghoff W, Stewart SF. CI-943, a potential antipsychotic agent. II. Neurochemical effects. J Pharmacol Exp Ther. 1989 Oct;251(1):113-22. PubMed PMID: 2571713.
7: Heffner TG, Downs DA, Meltzer LT, Wiley JN, Williams AE. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects. J Pharmacol Exp Ther. 1989 Oct;251(1):105-12. PubMed PMID: 2571712.
8: DeWald HA, Beeson NW, Hershenson FM, Wise LD, Downs DA, Heffner TG, Coughenour LL, Pugsley TA. Synthesis and potential antipsychotic activity of 1H-imidazo[1,2-c]pyrazolo[3,4-e]pyrimidines. J Med Chem. 1988 Feb;31(2):454-61. PubMed PMID: 2892936.
